Cibus stock crashes as investors panic over sudden public offering move
Cibus Inc., an agricultural biotechnology company specialising in gene editing, saw its shares tumble after announcing an underwritten public offering of its Class A common stock. On 17 September 2024, Cibus made public its intention to raise capital through this offering, leading to a sharp 1.75% decline in its share price to around $5.06 on […]